Surfacide Unveils Helios®+ UV-C System: The First Whole Room Microbial Reduction Device to Receive 510(k) Clearance from the U.S. Food and Drug Administration
Helios+ is the only FDA Class II Medical Device for Whole Room Microbial Reduction using continuous 254 nm germicidal UV light and 3 Emitters in a Single Cycle (Waukesha, WI) – June 3, 2025 – Surfacide, the industry leader in UV-C technology, is proud to announce the launch of its Helios+ UV-C System, the first […]
